Price and states served both move. Read them off the seller's own site before you enroll.How our reviews work →

NextMeds vs WeightCare

An in-depth comparison of two leading GLP-1 Providers

Some of the links on this page earn us money. If you sign up with a provider after following one, that provider may pay GLP Watchdog a commission. Learn more

By Ruth Calder · Enforcement Editor
Editorially reviewed & fact-checked against primary sources · How we verify contentLast reviewed
NextMeds logo

NextMeds

9.2
★★★★4.6/5

Best for: semaglutide at $79/month, 59% under the register median

Visit NextMeds
VS
WeightCare logo

WeightCare

6.6
★★★☆☆3.3/5

Best for: starting below a standard dose, with microdose tiers

Visit WeightCare

Two GLP-1 Providers chasing the same patients, trading off price, geography and what lands in the box differently. On our scoring, NextMeds opens cheaper — $79/mo against $215, and NextMeds finishes ahead, 9.2 to 6.6. What follows: the prices, what each plan actually covers, the six-dimension score, where each one is weak, and who should pick which.

Pricing

NextMeds

InjectableCompounded
$79/mo
semaglutide

Compounded Semaglutide Membership, drug included when prescribed, alongside telehealth visits, a care coach, a dietitian and shipping. $79 is the month-to-month rate read from the pricing section on 2026-08-14. The site headline reads 'from $49/mo': that is the 12-month prepaid term divided down, not a monthly price, and the ladder between them is 3-month $76, 6-month $73, 12-month $49. A summer promotion was running with a stated end of August 20, so $79 may itself be discounted.

InjectableCompounded
$109/mo
tirzepatide

Compounded Tirzepatide Membership, drug included when prescribed, alongside telehealth visits, a care coach, a dietitian and shipping. $109 is the month-to-month rate read from the pricing section on 2026-08-14. The advertised 'GLP-1 + GIP: $95' is the 12-month prepaid term divided down; the ladder is 3-month $105, 6-month $100, 12-month $95. A summer promotion was running with a stated end of August 20, so $109 may itself be discounted.

WeightCare

Semaglutide Monthly (all doses)Compounded
$399/mo
semaglutide

month-to-month, no commitment

Semaglutide 3-month planCompounded
$249/mo
semaglutide

3-month plan ($747); new patients & starter doses only

Semaglutide 6-month planCompounded
$215/mo
semaglutide

6-month plan

Semaglutide Micro-DoseCompounded
$249/mo
semaglutide

micro-dose program

Tirzepatide Monthly (covers 2.5-15 mg/week)Compounded
$499/mo
tirzepatide

month-to-month, covers all doses

Tirzepatide 3-month plan (up to 7.5 mg/week)Compounded
$299/mo
tirzepatide

3-month plan; standard dose; up to $333/mo

Tirzepatide 6-month plan (up to 7.5 mg/week)Compounded
$275/mo
tirzepatide

6-month plan; standard dose

Tirzepatide 3-month high-dose (up to 15 mg/week)Compounded
$450/mo
tirzepatide

3-month high-dose plan ($1,350)

Tirzepatide 6-month high-doseCompounded
$358/mo
tirzepatide

6-month high-dose plan ($2,150)

What’s included

NextMeds

Covered by the monthly price

Medication

In the price

Clinician visits

In the price

Shipping

In the price

Lab work

Not stated

Coaching

In the price

WeightCare

Covered by the monthly price

Medication

In the price

Clinician visits

In the price

Shipping

In the price

Lab work

Not stated

Coaching

Not stated

Score breakdown

Both providers are scored on the same six-dimension framework. The gradient bar marks the stronger side on each dimension.

NextMeds

9.2/10

Overall

WeightCare

6.6/10

Value25%

10.0A
vs
B
4.8

Effectiveness25%

10.0A
vs
B
10.0

User Experience15%

8.0A
vs
B
8.0

Trust & Safety15%

7.5A
vs
B
3.5

Accessibility10%

10.0A
vs
B
5.0

Support10%

8.5A
vs
B
7.0

Features & Coverage

FeatureNextMedsWeightCare
Starting Price$79/mo$215/mo
Features8 features5 features
States Available50Not disclosed
Compounded✓ Yes✓ Yes
Brand Name
FSA/HSA Accepted✓ Yes
FDA WarningsNone1 warning

About NextMeds

Membership is a single flat monthly charge, and inside it sit free shipping, a registered dietitian holding a license, a care coach working 1:1, telehealth visits and the drug itself where one is prescribed. Insurance is not billed. A free assessment online goes to a licensed provider, who adds a phone or video consult in states that demand one, then prescribes if it fits. Compounding pharmacies within the Next Meds network, all licensed, ship. Auto-renewal does not exist, cancellation is open, and all 50 states can order compounded tirzepatide and semaglutide.

Read our full NextMeds review →

About WeightCare

WeightCare charges $249-$399/mo for compounded semaglutide and $349/mo for tirzepatide, dispensed by FDA-registered, PCAB-accredited pharmacies. The company is based in Ft. Lauderdale, FL, and says it has taken on 85,000+ members since 2022. It publishes quality testing documentation covering potency and sterility per USP 797.

Read our full WeightCare review →

Pros & Cons

NextMeds

What we like

  • Semaglutide at $79 a month, 58% below the $189 median for the same drug and form across this register
  • Tirzepatide at $109 a month, 59% below the $267 median for the same drug and form across this register
  • Publishes a price on its own site before the medical questionnaire, so it can be compared without handing over health information
  • The monthly price is recorded as flat across doses, so it does not climb as the dose is titrated up
  • The monthly figure covers medication, consult, shipping, coaching
  • Coverage is published for all 50 states
  • No FDA warning letter matched this operator when we searched our enforcement register

Watch-outs

  • No dispensing pharmacy is named in our record, so its accreditation cannot be looked up from here
  • Its semaglutide and tirzepatide are compounded rather than FDA-approved, so they have not been reviewed by the agency for safety, effectiveness or manufacturing quality

WeightCare

What we like

  • Semaglutide at $215 a month, within the normal band around this register's $189 median for the same drug and form
  • Publishes a price on its own site before the medical questionnaire, so it can be compared without handing over health information
  • The monthly figure covers medication, consult, shipping

Watch-outs

  • No state list is on record here, so whether it serves your state cannot be confirmed from this page
  • No dispensing pharmacy is named in our record, so its accreditation cannot be looked up from here
  • 1 FDA warning letter matched to this operator in our enforcement register — read what the letter alleges, since a letter discloses a problem rather than disqualifying a seller
  • Its semaglutide and tirzepatide are compounded rather than FDA-approved, so they have not been reviewed by the agency for safety, effectiveness or manufacturing quality

Our Verdict

Winner: NextMeds

NextMeds takes it, 9.2 against 6.6, and it is especially strong on semaglutide at $79/month, 59% under the register median. WeightCare is no weak second and may fit you better on starting below a standard dose, with microdose tiers.

Choose NextMeds if…

You want semaglutide at $79/month, 59% under the register median and an opening price near $79 a month.

Choose WeightCare if…

You want starting below a standard dose, with microdose tiers and an opening price near $215 a month.

Ready to start? Vetted GLP-1 providers

Vetted telehealth providers that prescribe GLP-1 online.

No insurance needed · vetted by our editors

Some of the links on this page earn us money. If you sign up with a provider after following one, that provider may pay GLP Watchdog a commission. Learn more

7.0

MyDrHank

An oral route if you will not self-inject

6.0

SkinnyRx

Starting below a standard dose, with microdose tiers

9.4

Trimi Health

Knowing which pharmacy fills the vial — it names VialsRx

NextMeds vs WeightCare: FAQ

Glossary

The words sellers use, defined. Tap any term.

Continue exploring NextMeds and WeightCare head-to-heads in the same category.

Or see the full category ranking.

Novo Nordisk A/S owns the Wegovy®, Ozempic® and Rybelsus® marks; Eli Lilly and Company owns Mounjaro® and Zepbound®. Every other product name and mark on this page belongs to whoever owns it. No pharmaceutical manufacturer is affiliated with GLP Watchdog. See trademark disclaimer.